Hosted on MSN20d
Moderna and Other Vaccine Stocks Climb After Coronavirus News From China
Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday. Shares of Moderna (MRNA), Pfizer (PFE) and Novavax (NVAX) all gained Friday, a broadly downbeat ...
Clinical Trials Arena on MSN6d
Everest Medicines begins dosing in mRNA cancer vaccine trial
The trial is jointly conducted at the Fudan University Shanghai Cancer Center and Peking University Cancer Hospital.
Investopedia20d
Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in China
Adam Glanzman / Bloomberg via Getty Images Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday. Shares of Moderna (MRNA), Pfizer (PFE ...
Insider Monkey20d
Five Chinese Firms Dominate Friday’s Top 10 Gainers
Pharmaceutical giant Moderna Inc. saw its share prices grow by 5.34 percent on Friday to finish at $35.53 apiece following news that a new coronavirus with pandemic potential was discovered in China.
Nature3y
Arcturus—a clinical-stage mRNA therapeutics and vaccines company
Preclinical programs include wholly owned mRNA therapeutics for cystic fibrosis ... issued in the US, Europe, Japan, China and other regions. Arcturus’ development partners include Janssen ...
mskcc.org23d
In Early-Phase Pancreatic Cancer Clinical Trial, Investigational mRNA Vaccine Induces Sustained Immune Activity in Small Patient Group
Dr. Vinod Balachandran says mRNA vaccines could stimulate the immune system to recognize and attack pancreatic cancer cells. An experimental approach to treating pancreatic cancer with the messenger ...